Product Details for NDA 019901
ALTACE (RAMIPRIL)
1.25MG
Marketing Status: Prescription
2.5MG
Marketing Status: Prescription
5MG
Marketing Status: Prescription
10MG
Marketing Status: Prescription
1.25MG
Marketing Status: Prescription
Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1.25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 001
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
ALTACE (RAMIPRIL)
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 1.25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 001
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
2.5MG
Marketing Status: Prescription
Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 2.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 002
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
ALTACE (RAMIPRIL)
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 2.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 002
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
5MG
Marketing Status: Prescription
Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 003
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
ALTACE (RAMIPRIL)
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N019901
Product Number: 003
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
10MG
Marketing Status: Prescription
Active Ingredient: RAMIPRIL
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N019901
Product Number: 004
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: ALTACE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N019901
Product Number: 004
Approval Date: Jan 28, 1991
Applicant Holder Full Name: KING PHARMACEUTICALS LLC
Marketing Status: Prescription
Patent and Exclusivity Information